Skip navigation

Family history can trump breast cancer test

Women can be free of gene mutations and still be at risk, study finds

  Photo features
Grandmother sheds 140 pounds
Take a look at the amazing before and after photos of the newest Joy Fit Club members.
Image: Sheryl Crow
AP
  Famous breast cancer survivors
Movie stars, athletes and a former First Lady who've all beaten the disease share what inspired them to keep fighting.
Courtesy McCartney family
Miracle baby born twice
See photos from Macie Hope McCartney's incredible surgery and birth.
Image: The Biggest Loser; Michelle Aguilar
NBC
  Biggest Loser: Before & after
In season six, parents and children and husbands and wives battled the bulge together.  See their amazing weight loss. 

TODAY's Hoda Kotb explores issues that are important to your family.   Watch the show

20 - worst foods in America12 foods to shrink your stomach11 metabolism myths busted8 breakfast foods to avoid10 pounds to lose without even trying20 saltiest foods exposed
updated 11:53 a.m. ET Nov. 17, 2008

WASHINGTON - If breast cancer runs in the family, women can be at high risk even if they test free of the disease's most common gene mutations, sobering new research shows.

The genes BRCA1 and BRCA2 are linked with particularly aggressive hereditary breast cancer, and an increased risk of ovarian cancer, too. When a breast cancer patient is found to carry one of those gene mutations, her relatives tend to breathe a sigh of relief if they test gene-free.

But those headline-grabbing genes account for only about 15 percent of all breast cancer cases. Even in families riddled with breast cancer, a BRCA gene is the culprit only in roughly one family of every five that gets tested, said University of Toronto cancer specialist Dr. Steven Narod.

Story continues below ↓
advertisement | your ad here

So clearly members of those families remain at risk from other yet-to-be-found genes, but how much risk?

Narod tracked nearly 1,500 women from 365 breast cancer-prone families, who tested negative for BRCA1 and BRCA2 mutations.

After five years, those women had a fourfold higher risk than average women of developing breast cancer, Narod reported Monday at a meeting of the American Association for Cancer Research.

This is crucial information for women considering gene testing, said Georgetown University genetics counselor Beth Peshkin, who wasn't part of the study.

"This is contrary to what I think the common perception is," Peshkin said. "Unless a mutation is identified in the family, a negative test result doesn't provide reassurance."

The good news: Narod's study showed these women didn't have an increased risk of ovarian cancer, like BRCA1- and BRCA2-carriers do.

While the $3,000 BRCA tests are well-accepted, newer tests for other genes linked to breast cancer are coming on the market.

But "the family history is a much stronger predictor," stressed Narod. He recommends that such women take the anti-cancer drug tamoxifen and undergo MRI cancer checkups instead of easier mammograms "regardless of what other gene tests showed."

More on breast cancer | women's health

Copyright 2008 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.